A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
ConclusionsBlockage of binding of the SARS-CoV-2 spike protein with ACE2 in the presence of the 13AApi may prevent virus entry into host cells. Therefore, the 13AApi can be utilized as a promising therapeutic agent to combat coronavirus disease 2019.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research
More News: Coronavirus | COVID-19 | Drugs & Pharmacology | Pandemics | Respiratory Medicine | SARS | Toxicology